Seoul Pharma Revenue

In the year 2025, Seoul Pharma had annual revenue of 52.15B KRW, down -2.67%. Seoul Pharma had revenue of 13.61B in the quarter ending December 31, 2025, a decrease of -2.05%.

Revenue

52.15B

Revenue Growth

-2.67%

P/S Ratio

0.64

Revenue / Employee

303.19M

Employees

172

Market Cap

33.17B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	52.15B	-1.43B	-2.67%
Dec 31, 2024	53.58B	1.12B	2.14%
Dec 31, 2023	52.46B	2.40B	4.80%
Dec 31, 2022	50.06B	9.59B	23.71%
Dec 31, 2021	40.46B	-11.77B	-22.53%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
ChoA Pharmaceutical Co., LTD.	59.31B
Daesung Microbiological Labs.	25.99B
Pharmsville	12.73B
GeneBioTech Co. ,Ltd	90.79B
Hurum	99.01B
Korean Drug	62.51B
HLscience	16.71B
BIFIDO	19.68B

Revenue Rankings